Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies.
Thomas Dillinger Ludwig Boltzmann Institute Applied Diagnostics / Medical University of Vienna
Ludwig Boltzmann Institute Applied Diagnostics / Medical University of Vienna
University of Veterinary Medicine Vienna / Medical University of Vienna
Medical University Vienna
Gero Kramer Medical University Vienna
Medical University of Vienna
Ludwig Boltzmann Institute Applied Diagnostics / Medical University of Vienna
Ludwig Boltzmann Institute Applied Diagnostics / Medical University of Vienna
Austrian Institute of Technology
Ludwig Boltzmann Institute Applied Diagnostics
Medical University Vienna
Nicolai Hübner Medical University Vienna
Katharina Rebhan Medical University Vienna
Andreas Tiefenbacher Ludwig Boltzmann Institute Applied Diagnostics / Medical University of Vienna
Stefanie Brezina Medical University of Vienna
Sarah Ely Ludwig Boltzmann Institute Applied Diagnostics / Medical University of Vienna
Elisa Redl Medical University of Vienna
Sandra Domazet Ludwig Boltzmann Institute Applied Diagnostics
Madeleine Kuroll Ludwig Boltzmann Institute Applied Diagnostics
Carlos Uziel Pérez Malla Ludwig Boltzmann Institute Applied Diagnostics
Janine Scheibelreiter Medical University of Vienna
Melanie R. Hassler Medical University of Vienna
Ines Stelzer Ludwig Boltzmann Institute Applied Diagnostics / Medical University of Vienna
Ludwig Boltzmann Institute Applied Diagnostics / Medical University of Vienna
Walter Pulverer Austrian Institute of Technology
BioMed Central
Abstract not available
Englisch
2022
Dieses Werk bzw. dieser Inhalt steht unter einer
CC BY 4.0 - Creative Commons Namensnennung 4.0 International Lizenz.
CC BY 4.0 International
http://creativecommons.org/licenses/by/4.0/
Biomarkers, Tumor; Computational Biology; Disease Management; Disease Susceptibility; DNA Methylation; Epigenesis, Genetic; Epigenomics; Gene Expression Profiling; Humans; Liquid Biopsy; Male; Prognosis; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome